NSAID enteropathy

  • A. J. Morris


Damage to the gastrointestinal mucosa by nonsteroidal anti-inflammatory drugs (NSAID) is the most common iatrogenic disease known to man. The term “NSAID enteropathy” describes a specific small intestinal disease caused by NSAID. It is increasingly recognized that small bowel damage caused by these drugs can result in significant morbidity and mortality in patients with arthritis. Recognition that NSAID gastrointestinal damage extends beyond the distal duodenum has allowed clinicians to improve management of these patients with appropriate investigation and treatment. Small bowel endoscopy has proven pivotal in the investigation of patients with suspected NSAID enteropathy and has allowed studies of early pathological changes of NSAID enteropathy in man.


Small Bowel Distal Duodenum Small Bowel Lesion Small Bowel Bleeding Early Pathological Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested reading

  1. Morris AJ, Potter V, Capell HA, Sturrock RD, Lee FD, MacKenzie JF (1995) Jejunal lesions in human non steroidal anti inflammatory drug (NSAID) enteropathy. Gut 36 [Suppl 1]:T 153Google Scholar
  2. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF (1991) Enteroscopic diagnosis of small bowel ulceration in patients receiveng non steroidal anti inflamatory drugs. Lancet 337:520PubMedCrossRefGoogle Scholar
  3. Morris AJ, Wasson LA, MacKenzie JF (1992) Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33:887–889PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1998

Authors and Affiliations

  • A. J. Morris

There are no affiliations available

Personalised recommendations